Novartis Investigative Site

Strasbourg, France 67098

0 studies enrolling now · 4 studies all time

What they study most

Advanced Neuroendocrine Tumors of Pancreatic Origin, Carcinoid Tumor, Ectopic ACTH Syndrome, Malignant Carcinoid Syndrome, Nelson Syndrome, Pancreatic Neoplasm, Pituitary Neoplasm, Symptomatic Refractory Resistant Carcinoid Disease

Studies at this site

• Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin — Stopped early
• Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors — Completed
• Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor — Completed
• Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease — Completed